Table 2 Cumulative incidence rates of fracture types in case and control groups by time points.

From: Fractures incidence and its association on mortality in multiple myeloma patients: a nationwide cohort study (CAREMM-2105 study)

Type of fracture

Cumulative incidence rates (95% CI)

P

At 2 years

At 4 years

At 6 years

Any fracture

0.001

 Case

3.1 (2.7–3.5)

7.3 (6.7–7.9)

10.2 (9.4–11.0)

 

 Control

1.5 (1.3–1.7)

4.9 (4.5–5.3)

8.3 (7.5–9.1)

 

Vertebral fracture

 < 0.001

 Case

1.9 (1.7–2.1)

4.4 (4.0–4.8)

6.1 (5.5–6.7)

 

 Control

0.8 (0.6–1.0)

2.3 (1.9–2.7)

4.1 (3.5–4.7)

 

Hip fracture

0.01

 Case

0.4 (0.2–0.6)

1.1 (0.9–1.3)

1.4 (1.2–1.6)

 

Control

0.1 (0.1–0.1)

0.5 (0.3–0.7)

0.8 (0.6–1.0)

 

Upper limb fracture

0.153

 Case

0.6 (0.4–0.8)

1.6 (1.4–1.8)

2.2 (1.8–2.6)

 

 Control

0.5 (0.3–0.7)

1.6 (1.4–1.8)

2.8 (2.4–3.2)

 
  1. P P-value; Cumulative incidence rates are presented as % (95% CI); the p-value represents the Gray’s test result.